Literature DB >> 14627556

Guidelines for contrast media from the European Society of Urogenital Radiology.

Henrik S Thomsen1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14627556     DOI: 10.2214/ajr.181.6.1811463

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  26 in total

1.  Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction.

Authors:  Bing Qiao; Jie Deng; Yi Li; Xiaozeng Wang; Yaling Han
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!

Authors:  Ulf Nyman; Barbara Elmståhl; Peter Leander; Torsten Almén
Journal:  Eur Radiol       Date:  2008-04-04       Impact factor: 5.315

Review 3.  Blood pool contrast agents for venous magnetic resonance imaging.

Authors:  Irai S Oliveira; Sandeep S Hedgire; Weier Li; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

4.  One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy.

Authors:  Rosália P Padovani; Teresa S Kasamatsu; Claudia C D Nakabashi; Cleber P Camacho; Danielle M Andreoni; Eduardo Z Malouf; Marilia M S Marone; Rui M B Maciel; Rosa Paula M Biscolla
Journal:  Thyroid       Date:  2012-07-24       Impact factor: 6.568

5.  Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

Authors:  J Nicholas O'Donnell; Cybele Ghossein; Nathaniel J Rhodes; Jessica Peng; Tina Lertharakul; C Kim Pham; Marc H Scheetz
Journal:  J Infect Chemother       Date:  2017-01-18       Impact factor: 2.211

6.  Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.

Authors:  Geng Qian; Chang-Fu Liu; Jun Guo; Wei Dong; Jin Wang; Yundai Chen
Journal:  Clin Cardiol       Date:  2019-01-07       Impact factor: 2.882

7.  Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.

Authors:  Beibei Han; Yongguang Li; Zhifeng Dong; Qing Wan; Hong Shen; Jingbo Li; Meng Wei; Chengxing Shen
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

8.  Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients.

Authors:  Kang Hyu Lee; Sang Rok Lee; Kyung Pyo Kang; Huy Jung Kim; Sun Hwa Lee; Kyoung-Suk Rhee; Jei Keon Chae; Won Ho Kim; Jae Ki Ko
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

9.  One-molar gadolinium chelate (gadobutrol) as a contrast agent for CT angiography of the thoracic and abdominal aorta.

Authors:  José M Esteban; Antonio Alonso; Vicente Cervera; Vicente Martínez
Journal:  Eur Radiol       Date:  2007-02-07       Impact factor: 5.315

10.  No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.

Authors:  S Langner; S Stumpe; M Kirsch; M Petrik; N Hosten
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-04       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.